News

• BioNTech Announces Second Quarter 2020 Financial Results and Corporate Progress
  08/11/2020 / 12:03 - GlobeNewswire
•  
• Merus Announces Financial Results for the Second Quarter and Provides Business Update
  08/06/2020 / 22:07 - GlobeNewswire
•  
• Coherus BioSciences Reports Second Quarter 2020 Financial Results
  08/06/2020 / 22:02 - GlobeNewswire
•  
• Intellia Therapeutics Announces Second Quarter 2020 Financial Results
  08/06/2020 / 13:30 - GlobeNewswire
•  
• US opens higher after positive earnings reports
  08/05/2020 / 15:30 - TeleTrader
•  
• Regeneron's net income jumps 365% to $897M in Q2
  08/05/2020 / 12:35 - TeleTrader
•  
• Kiniksa Reports Second Quarter 2020 Financial Results and Highlights Recent Pipeline and Corporate Activity
  07/30/2020 / 13:30 - GlobeNewswire
•  
• Ziopharm Oncology to Report Second Quarter 2020 Financial Results and Host a Conference Call and Webcast on August 6, 2020
  07/28/2020 / 15:00 - GlobeNewswire
•  
• Merus Appoints Andrew Joe, M.D., as Chief Medical Officer
  07/27/2020 / 14:00 - GlobeNewswire
•  
• Regeneron falls over 4% ahead of lower drug prices expectations
  07/24/2020 / 17:57 - TeleTrader
•  
• Ziopharm Oncology Names James Huang to Board of Directors
  07/22/2020 / 14:30 - GlobeNewswire
•  
• Vyriad Announces Initiation of Phase 2 Trial in Multiple Cancer Indications
  07/20/2020 / 16:00 - GlobeNewswire
•  
• Kiniksa Announces U.S. Orphan Drug Designation for Rilonacept for the Treatment of Pericarditis
  07/16/2020 / 13:30 - GlobeNewswire
•  
• Ziopharm Oncology Announces Initiation of Phase 1 Trial Evaluating Rapid Personalized Manufacturing CAR-T Technology in Patients with Relapsed CD19+ Leukemias and Lymphomas
  07/09/2020 / 22:15 - GlobeNewswire
•  
• Regeneron gets $450M for vaccine advancement
  07/07/2020 / 14:40 - TeleTrader